CUVITRU is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients ≥2 years. CUVITRU is for subcutaneous use only.
Your patient with primary immunodeficiency (PI) may have questions regarding cost and coverage.
We are here to help. In this section, we have several resources to help your patient along the insurance journey.
The first question your patients may have is whether their health insurance covers CUVITRU and how much it will cost.
A benefits investigation can uncover these answers. Call the patient’s health plan on their behalf to determine coverage and out-of-pocket costs. Be sure to have your patient’s full insurance information to get the process started.
Depending on a patient’s medical or prescription drug benefit, you may be required to submit a prior authorization (PA) before your patient can receive treatment with CUVITRU. Each health plan has different requirements, so it’s always good to call and confirm their policy.
Sometimes PAs do get denied. You and your patient are able to appeal the decision and it’s important to understand why it was denied in the first place. Some common reasons for denial:
These resources are at your disposal to support the PA process for CUVITRU
If a patient is prescribed CUVITRU and needs co-pay assistance, you can direct the patient to enroll in Takeda Patient Support. The co-pay assistance program can cover up to 100% of your patient’s out-of-pocket co-pay costs, if they’re eligible.*† A support specialist can review your patient’s coverage and determine eligibility.
ELIGIBILITY*:
If your patient has government insurance, Takeda Patient Support can help answer questions about their prescribed Takeda treatment coverage. This includes federal or state insurance such as Medicare, Medicare Advantage, or Medicaid.
If your patient can’t afford treatment, Takeda Patient Support may be able to connect them to programs that may help.
Complete the Start Form and fax to 1-855-268-1826.
*Must meet eligibility requirements.
†IMPORTANT NOTICE: The Takeda Patient Support Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Co-payment assistance under the Program is not transferable.The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your patient’s insurance provider. If your patient’s insurance situation changes, they must notify the Program immediately at 1-855-268-1825. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.
CUVITRU offers helpful resources so that your office can sort through the complexities of the reimbursement process. Find downloadable resources and information needed to process billing and diagnostic codes and claim forms.
Review Important Safety Information, including contraindications and other specific warnings and precautions to consider when prescribing and monitoring patients treated with CUVITRU.
Learn if CUVITRU is right for your patients with the HelloCUVITRU Free Trial Program.
This free trial offer is solely intended to allow new patients to try CUVITRU and help determine, along with their HCP, if it is right for them.
With the HelloCUVITRU program, the entire cost of their first 4 infusions of CUVITRU, along with ancillary supplies, pump, and administration are all covered.
Get your eligible* patients started today by following the process below.
1
Download and complete
Download and complete the HelloCUVITRU Free Trial Request Form (see link below) and fax to 866-861-1752.
HCP can check a box on the form if they want to have the pharmacist determine ramp-up dosing.
Please note that the pharmacist will call the HCP’s office to clarify ramp-up dosing if it is not written or the box isn’t checked.
2
Receive a welcome call
Patients will receive a welcome call from a HelloCUVITRU Free Trial Case Manager.
The Case Manager will:
3
Begin CUVITRU treatment
The patient will receive their CUVITRU infusions either at home or in the office, depending on what you choose. After completion of the program, communication will be sent to the physician documenting the infusion rate and patient training.
*Eligible patients must have an ICD-10 code verifying diagnosis of PI, be a new patient not currently using CUVITRU, and not have previously enrolled in the HelloCUVITRU Program. Additional terms apply.
There is no obligation for the patient to continue use of CUVITRU after the free trial has been completed. HelloCUVITRU is not meant to induce or require future or continuing prescriptions of CUVITRU.
Get organized
Prep and draw CUVITRU
Start infusion
Remove needle(s) and wrap up
The infusion process is broken up into four sections to help make it easier for you to remember. You may remember the “ABCs to infuse.” TRU4 replaces those! Why? Because we wanted to get more descriptive with the sections to make the process easier to remember. Learn more on our FAQ page.
Explore comprehensive resources for your patients to help support them with their CUVITRU treatment.
MyIgSource is committed to helping your patients manage a life with primary immunodeficiency at diagnosis and throughout their PI journey. From advocacy to learning about diagnosis, management, and living with PI, your patients and their caregivers, regardless of treatment, have access to:
If English is not your patient’s preferred language, we can assist them in a language of their choosing.
*If your patients’ medication is dispensed by specialty pharmacy.
Must meet eligibility requirements. IMPORTANT NOTICE: The Takeda Patient Support Co-Pay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs). No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. The Program cannot be combined with any other rebate/coupon, free trial, or similar offer. Copayment assistance under the Program is not transferable. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your patient’s insurance provider. If your patient’s insurance situation changes, they must notify the Program immediately at 1-866-861-1750. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice.
Visit our convenient online enrollment portal at TakedaPatientSupport.com/hcp/
cuvitru/enroll_your_patient. You can also enroll your patient by faxing the completed Start Form to 1-866-861-1752.